Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 14,200 shares at $61.48 ($866K) on 2019-12-19, disclosed to the SEC on 2019-12-20.
Open-market sale of $866k TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.69 | 9,230 | $560K | 64.7% |
| 2 | $61.48 | 4,970 | $306K | 35.3% |
| Total | $60.97 avg | 14,200 | $866K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |